Jian Huang

7PUBLICATIONS
34CO-AUTHORS
Adolescent healthHaematological tumoursHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 05, 2026
Age as a core disease modifier: Distinct clinical, molecular and prognostic landscapes of essential thrombocythaemia in adolescents and young adults.

|Oct 08, 2025
Efficacy and safety of OB756 (a novel selective JAK2 inhibitor) for essential thrombocythemia in patients intolerant of or resistant to hydroxyurea or intolerant of interferon: A phase 2, open-label, multicenter study.

Jian Huang, Rumeng Li, Tiejun Gong

|Jan 15, 2025
α-Actinin-1 deficiency in megakaryocytes causes low platelet count, platelet dysfunction, and mitochondrial impairment.

Xiangjie Lin, Hanchen Gao, Min Xin

|Jul 24, 2024
A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy.

Xiaoshuai Zhang, Bingcheng Liu, Jian Huang

|Dec 11, 2022
Targeted Next-Generation Sequencing Identifies Additional Mutations Other than BCR∷ABL in Chronic Myeloid Leukemia Patients: A Chinese Monocentric Retrospective Study.

Shiwei Hu, Dan Chen, Xiaofei Xu

Pageof 2

Frequent Collaborators

3 joint publications

Jie Jin

2 joint publications

Qian Jiang

2 joint publications

Hongyan Tong

1 joint publications

Xiaofei Xu